Xstrahl

Xstrahl is a prominent global provider specializing in the development and delivery of superficial radiation therapy devices and advanced preclinical radiation research systems. The company is actively engaged in connecting experts to further the fields of radiation therapy and research. Through innovation, Xstrahl supports advancements in X-ray technology applications. Notably, the company offers solutions for treating non-melanoma skin cancers, such as basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), using low-energy radiation therapy, comparable to surgical treatment outcomes. Additionally, radiotherapy options are provided for benign conditions like keloid scarring, and Dupuytren’s contracture, emphasizing non-invasive methods. Xstrahl is heavily invested in palliative care solutions, aiming to enhance patient comfort by administering low doses of radiation beneficial for soft tissue metastases.